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Insulin signalingon is known to be associated with insulin resistance and type2 diabetes. Here we
show that incubation of L6 skeletal muscle cells with palmitate signiﬁcantly increased NF-κB p65 and NF-κB
p50 expression along with their phosphorylation. NF-κB p65 siRNA inhibited palmitate induced over-
expression of NF-κB p65 indicating palmitate effect on transcriptional activation. RT-PCR and real time PCR
experiments also showed a signiﬁcant increase in NF-κB p65 gene expression due to palmitate.
Overexpression of NF-κB p65 by palmitate was linked to impairment of insulin activity. Palmitate effect on
NF-κB gene and protein expression was found to be mediated by phospho-PKCɛ as calphostin C (an inhibitor
of PKC) and ɛV1 (PKCɛ translocation inhibitor) signiﬁcantly reduced NF-κB expression. To understand the
underlying mechanism, we puriﬁed NF-κB and pPKCɛ from palmitate incubated skeletal muscle cells and
their interaction in cell free system demonstrated the transfer of phosphate from PKCɛ to NF-κB. This
prompted us to transduct pPKCɛ to the skeletal muscle cells. These cells showed increased amount of pNF-κB
and NF-κB. Excess of NF-κB p65 pool thus created in the cells made them insulin resistant. Addition of NF-κB
p65 siRNA and SN50 inhibited palmitate induced NF-κB p65 expression indicating NF-κB regulation of its
gene expression. Increase of NF-κB did not affect the activation of IKK/IκB indicating NF-κB p65 expression to
be a distinct effect of palmitate. Since NF-κB p65 is linked to several diseases, including type2 diabetes, this
report may be important in understanding the pathogenicity of these diseases.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
NF-κB plays a critical role in implementing the pathogenesis in a
number of inﬂammatory diseases including type2 diabetes [1–3]. It is
well known that free fatty acids (FFAs) are linked to insulin resistance
and type2 diabetes [4–9]. Increase in tissue lipid levels is inversely
related to insulin sensitivity [10,11] and short termFFA infusion induces
insulin resistance [12–17]. Patients suffering from insulin resistance
and type2 diabetes show excess plasma FFA level and lowering of the
FFA level normalized insulin sensitivity in these patients [18–21].
Interestingly, inhibitor of κB kinase (IKK) has been implicated in the
mediation of FFA induced insulin resistance [17,21]. Inhibitory κB
proteins (IκBs) restrict the NF-κB dimer in the cytoplasm, phospho-
rylation of IκBα by IKK induces its polyubiquitination and proteasomal
degradation thus making NF-κB (p50/p65) free for its translocation to8; fax: +91 3463 261176.
acharya).
Science of the Czech Republic,
ll rights reserved.the nucleus [3,22,23]. NF-κB, a family of transcription factors, regulates
the expression of proinﬂammatory and anti-apoptotic genes [24,25].
FFAspromoteNF-κB activity that in turn targets geneproducts involved
in the pathogenesis of insulin resistance [21,26].
FFA has been shown to activate NF-κB and its nuclear translocation
that compromised insulin sensitivity in skeletal muscle cells; inhibi-
tors of IKK/IκB/NF-κB pathway prevent FFA induced impairment of
insulin activity [22]. A link between NF-κB and type2 diabetes is
probablymaintained by inﬂammatory cytokines. Levels of a number of
pro-inﬂammatory cytokines are elevated in type2 diabetes along with
the activation of NF-κB [3,27]. Incubation of skeletal muscle cells with
palmitate increased IL-6 gene expression and secretion via activation
of NF-κB and PKC which causes insulin signaling defects [28]. FFA may
induce insulin resistance via the involvement of activated NF-κB and
novel PKCs [28–30]. We have recently demonstrated that PKCɛ plays a
major role in FFA induced insulin resistance in skeletalmuscle cells and
adipocytes by downregulating insulin receptor (IR) gene expression
[31–33]. However, whether the activation of PKCɛ by FFA could be
linked to NF-κB was not addressed by us.
In the present investigation we have witnessed an unexpected
event. In our attempt to illustratewhether NF-κB is associatedwith the
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detected an increase in NF-κB protein in the skeletal muscle cells
incubated with palmitate. Earlier reports in this ﬁeld demonstrated
that FFA impaired insulin activity in skeletal muscle cells by activating
NF-κB through IKK/IκB pathway.We have found that FFA i.e., palmitate
increased the expression of NF-κB protein by triggering NF-κB gene.
This being an unusual ﬁnding is expected to attract attention of other
investigators since NF-κB is related to the expression of a spectrum of
genes that are associated with various kinds of pathogenic conditions
including insulin resistance and type2 diabetes.
2. Materials and methods
2.1. Materials
All tissue culture materials were obtained from Gibco-BRL, Life
Technologies Inc., Gaithersburg, USA. Palmitate and porcine insulin
were purchased from Sigma Chemical Company, St. Louis, MO, USA.
[3H] 2-deoxyglucose (Speciﬁc activity: 12.0 Ci/mmol) and [γ-32P] ATP
(Speciﬁc activity: 6000 Ci/mmol) were from GE Healthcare, Asia
Paciﬁc Region, Singapore. Calphostin C, PKCɛ translocation inhibitor
peptide EAVSLKPT (ɛV1) and SN50 were purchased from Calbiochem,
Darmstadt, Germany. Antibodies utilized included anti-NF-κB p65,
anti-pNF-κB p65, anti-NF-κB p50, anti-pNF-κB p50, anti-IKKβ, anti-
pIKK, anti-IκBα, anti-pIκBα, anti-PKCɛ and anti-pPKCɛ antibodies
were purchased from Santa Cruz Biotechnology Inc., California, USA.
Alkaline phosphatase conjugated anti-rabbit, anti-goat and anti-
mouse secondary antibodies and Control and NF-κB p65 (h) siRNA
were also purchased from Santa Cruz Biotechnology Inc., California,
USA. GFP-Glut 4 construct was a kind gift from Dr. Jeffrey E. Pessin,
Chairman and Professor of the Department of Pharmacology, The
University of Illinois, USA. The other chemicals and reagents used in
the present investigationwere purchased from Sigma Chemical Co., St.
Louis MO, USA.
2.2. Cell culture and treatments
L6 skeletal muscle cell line was procured from the National Centre
for Cell Science, Pune, India and was cultured in a similar manner as
describedbyus previously [32,33]. Brieﬂy, L6 skeletalmuscle cellswere
cultivated in DMEMmedium supplemented with 10% fetal calf serum,
25mMglucose, penicillin (100 U/ml) and streptomycin (100 μg/ml) in a
humidiﬁed 95% O2/5% CO2 atmosphere at 37 °C. Conﬂuent cells were
trypsinized and reseeded in DMEM containing glucose, reduced serum
(2%) and antibiotics. Media was changed every 2 days and ﬁnally
myotube differentiation was completed after 6 days of culture.
Myotubes were treated with palmitate (lipid-containing media were
prepared by conjugation of free fatty acid with bovine serum albumin
by following our earlier description [32]) at different doses (0.5, 0.75
and 1.0 mM) and time periods (0 h, 2 h, 4 h and 6 h) without or with
insulin (100 nM) or without any of them (control). For experiments
with different inhibitors such as SN50 (50 μg/ml), Calphostin C
(100 nM) and PKCɛ translocation inhibitor ɛV1 (150 μg/ml) treatments
are described at respective places. 2×105 cells were plated in a six well
culture plate and NF-κB p65 siRNA (20 pmol/μl) was transfected using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) and Opti-MEM
reduced serum medium according to the manufacturer's protocol.
After 24 h of transfection, cells were washed with DMEM. Transfected
cells were then used for different experiments.
On termination of incubations, cells were washed twice with ice-
cold PBS and harvested with trypsin (0.25%)–EDTA (0.5 mM). Cell
pellets were resuspended in lysis buffer (1% NP-40, 20 mM HEPES
(pH 7.4), 2 mM EDTA, 100 mM NaF, 10 mM sodium pyrophosphate,
1 mM sodium orthovanadate, 1 μg/ml leupeptin, 1 μg/ml aprotinin,
1 μg/ml pepstatin and 1 mM PMSF) and sonicated on ice for 10 min
(with 20 s pulse, 2 min between each pulse). Lysates were centrifugedfor 10 min at 10,000 g and protein concentrations of supernatant were
determined by the method of Lowry et al. [34].
2.3. [3H] 2-deoxyglucose uptake
[3H] 2-deoxyglucose uptake in L6 myocytes was conducted
according to an earlier method described from our laboratory [35].
L6myocyteswere serum starved overnight in Kreb's Ringer Phosphate
(KRP) buffer (12.5 mMHEPES, pH 7.4, 120 mMNaCl, 6 mM KCl, 1.2 mM
MgSO4, 1 mM CaCl2, 0.4 mM NaH2PO4, 0.6 mM Na2HPO4) supple-
mented with 0.2% bovine serum albumin. Cells were incubated
separately for 4 h in the presence or absence of palmitate (0.75 mM)
followed by 30 min incubation with porcine insulin (100 nM).
Incubations in the absence of any of these chemicals were taken as
the control. After 25 min, [3H] 2-deoxyglucose (0.4 nmol/ml) was
added to each of the incubations 5 min before the termination of
experiment. Cells were washed thrice with ice-cold KRP buffer in the
presence of 0.3 mM phloretin to correct the glucose uptake data from
simple diffusion and non-speciﬁc trapping of radioactivity. Cells were
harvested with trypsin (0.25%)–EDTA (0.5 mM), solubilized with 1%
NP-40 and [3H] 2-deoxyglucose (2-DOG) was measured in a Liquid
Scintillation counter (Perkin Elmer, Tri-Carb 2800TR).
2.4. Gel ﬁltration and immunoafﬁnity chromatography
To prepare NF-κB rich fraction, gel ﬁltration chromatography was
performed on a Sephadex G-75 (Amersham Pharmacia Biotech AB,
Uppsala, Sweden) column (2×50 cm) equilibrated with Tris–HCl
buffer (10 mM Tris–HCl, pH-7.4) by following an earlier description
from this laboratory [36]. The ﬂow rate was maintained at 1 ml/min
and 1.0 ml fractions were collected just after loading the skeletal
muscle cell lysate. A standard gel ﬁltration molecular weight marker
from Sigma Chemical Co., St. Louis, USA, was run to determine the
approximate molecular weight of the eluted proteins. Fractions
around 66 kDa were pooled, lyophilized to reduce the volume and
subjected to 10% SDS-PAGE. To identify NF-κB p65 there, the gel was
transferred to PVDF membrane for Western blot analysis. It was
further puriﬁed by immunoafﬁnity chromatography where CNBr
activated Sepharose 4B beads were conjugated with the anti-NF-κB
p65 antibody. Coupling of the antibody was carried out by following
the procedure previously described from this laboratory. Brieﬂy, NF-
κB p65 antibody coupled Sepharose 4B beads were loaded on a 5 ml
column. Unbound antibody was removed by washing with coupling
buffer (pH-8.5) followed by acetate buffer (0.1 M, pH-4.0). The
remaining active groups on the beads were blocked with glycine
buffer (0.2 M, pH-8.0). The sample was loaded on the column and kept
overnight at 4 °C. The unbound proteins were elutedwith 10mMTris–
HCl buffer, pH-7.4 while NF-κB p65 bound to the ligand was eluted
with elution buffer (10 mM Tris–HCl, pH-7.4) containing 2.0 M KI as a
chaotropic agent. The volume of each eluted fraction was 1.0 ml. The
fractions were collected until the O.D. at 280 nm reached the baseline,
pooled and dialyzed against the buffer (10 mM Tris–HCl, pH-7.4) and
lyophilized. The purity of NF-κB p65 was examined in a 10% SDS-PAGE
where it gave a single protein band which also crossreacted with anti-
NF-κB p65 antibody.
2.5. Electrophoresis and immunoblotting
60 μg protein from the lysates of control and treated cells was
resolved on 10% SDS-PAGE and transferred to PVDF membranes
(Millipore, Bedford, MA 01730) through transfer buffer (25 mM Tris,
193 mM glycine, 20% methanol, pH 8.5) for 1.5 h. Western blot analysis
was performed by following themethod described previously from this
laboratory [31–33,35] using phospho-speciﬁc antibodies such as anti-
pPKCɛ (anti-rabbit), anti-pNF-κBp65 (anti-rabbit), anti-pIκBα (anti-
mouse), anti-pIKK (anti-goat), anti-pNF-κB p50 (anti-rabbit) antibodies.
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antibodies such as anti-NF-κB p65 (anti-rabbit), anti-IκBα (anti-rabbit),
anti-IKK β (anti-goat), anti-NF-κB p50 (anti-rabbit), anti-PKCɛ (anti-
rabbit) and anti-β actin antibodies. Membrane bound primary anti-
bodies were visualized using corresponding secondary antibodies at
1:1000 dilutions, which were tagged with alkaline phosphatase and
were developed with corresponding substrates, 5-bromo 4-chloro
3-indolyl phosphate/nitroblue tetrazolium (BCIP/NBT). Band inten-
sities were quantiﬁed by utilizing Image J software (NIH, Bethesda, MD).
2.6. Reverse transcription PCR and real-time quantitative PCR
RNA isolation from control and treated skeletal muscle cell
incubations was performed using the Tri reagent RNA extraction kit.
RT-PCR of isolated RNA was carried out using RT kit from First strand
cDNA synthesis kit, Fermentas Life Sciences, Revert Aid™, Hanover,
MD, USA, following a previous description from this laboratory [33].
Alteration in NF-κB p65 gene expression was observed in semi-
quantitative RT-PCR and it was thereafter conﬁrmed with the help of
real-time quantitative PCR (qPCR) by using iCycler (Bio-Rad) real-time
PCR machine and Dynamo SYBR Green real-time qPCR kit (Finzymes,
Espoo, Finland). 3 μg of total RNA from each sample was reverse
transcribed and PCR was performed with gene speciﬁc primers in a
total volume of 20 μl in the following real-time PCR conditions: initial
activation step (95 °C—15 min), cycling step (denaturation 95 °C—30 s,
annealing at 55 °C—30 s, and ﬁnally extension for 72 °C—30 s×
40 cycles) followed by their melt curve analysis (55–60 °C,15 s, 40×). A
house keeping gene, gapdh, was simultaneously ampliﬁed in separate
reactions and acted as an internal control. The CT value was corrected
by CT reading of corresponding gapdh controls. Data from three
determinations (means±SEM) are expressed as relative expression
level. The following primer pairs were used in real time PCR:
NF-κB sense: 5′-CCATCAGGGCAGATCTCAAACC-3′;
antisense: 5′-GCTGCTGAAACTCTGAGTTGTC-3′, product of 380 bp;
gapdh: sense: 5′-GCCATCAACGACCCCTTC-3′;
antisense: 5′-AGCCCCAGCCTTCTCCA-3′ product of 290 bp.
The cycle number at which NF-κB p65 (RelA) transcripts were
detectable (CT) was normalized to that of gapdh, referred to as ΔCT.
2.7. EMSA and supershift assay
Nuclear extracts were prepared from control, palmitate, NF-κB p65
siRNA and SN50 treated cells as described previously [37]. The speciﬁc
oligonucleotide probes were end labelled with γ32P-dATP using T4
polynucleotide kinase (NEB, Beverly, MA). The probes used in EMSAwere
designed in analogy with known proximal promoter sequence of NF-κB
gene. The probes were incubated with 10 μg of nuclear extracts in a 20 μl
of binding reaction (20% glycerol, 100 mM Tris–HCl pH-8.0, 300 mMKCl,
25 mM MgCl2, 500 μg/ml BSA) on ice for 45 min. For supershift assays,
wild type probe was incubated with 10 μg nuclear extract in a 20 μl of
binding reaction for 20 min on ice and then 4 μg of NF-κB p65 speciﬁc
antibody was added, followed by incubation on ice for an additional
30 min. Reaction mixture were resolved on 5% polyacrylamide gel using
0.5× TBE running buffer at 150 V for 3.5 h in a Bio-Rad electrophoresis
system. The gelswere transferred to 3MWhatmanﬁlter paper, dried and
exposed to ﬁlms. The probes used in EMSA are mentioned.
Wild type probe: 5′-AGTTGAGGGGACTTTCCCAGGC-3′;
Mutant probe: 5′-AGTTGAGGCGACTTTACCAGGC-3′.
2.8. GFP-Glut 4 transfection, transduction of pPKCɛ protein
and immunoﬂuorescence
GFP-Glut 4 transfection was carried out according to our previous
description [35]. Brieﬂy, L6 skeletal muscle cells were plated on60 mm plate containing cover slips and maintained in an air/CO2
(19:1) atmosphere in DMEM supplemented with 10% (v/v) FBS and
100 μg/ml penicillin/streptomycin. After 8 h, cells were washed with
DMEM free from FBS. Plasmid DNA of GFP-Glut 4 (2 μg) was used to
transfect 2×105 cells on each 60mm plate with Lipofectamine reagent
in accordance with the manufacturer's protocol (Invitrogen, USA).
After 48 h of transfection (transfection efﬁciency: 65–70%) cells were
incubated without (control) or with insulin (100 nM) for 6 h. To a
batch of GFP-Glut 4 transfected cells pPKCɛ was delivered as pPKCɛ–
Triton X-100 complex and then subjected to insulin incubation. On
termination of the incubation, cells on the cover slips were ﬁxed in
paraformaldehyde (3.5%) and mounted on glass slides. The cover slips
were examined for translocation of GFP-Glut 4 under laser scanning
confocal microscope (Leica Corp., Rockleigh, NJ).
Delivery of pPKCɛ protein into the skeletal muscle cells was
performed by following a method described earlier [38] with certain
modiﬁcations. Puriﬁed pPKCɛ was obtained in the similar manner as
described below under “Autoradiography of radiolabelled PKCɛ and
NF-κB” except the use of non-radioactive ATP in the incubation
medium. Brieﬂy, Triton X-100 was sonicated for 1 min andmixed with
10 μg of puriﬁed pPKCɛ protein in PBS (Phosphate buffer saline,
50 mM, pH-7.4 and 0.15 mM NaCl) to form a complex at room
temperature for 30 min. This complex mixture was then kept at 4 °C
for another 30 min. The complex formed was diluted 10 times with
DMEM containing 10% FBS. Cells grown to 95% conﬂuency were
incubated with the protein–Triton X-100 complex for 2 h and then
washed extensively with DMEM. A portion of skeletal muscle cells
thus transfected with pPKCɛ protein was processed for immunoﬂuor-
escence study in the following manner. Skeletal muscle cells were
seeded on sterile uncoated 22 mm coverslips and grown for 2 days in
DMEMwith 10% fetal bovine serum (FBS) in a humidiﬁed atmosphere
of 95% O2/5% CO2 at 37 °C. Cells were then subjected to ﬁxation with
3.5% paraformaldehyde in HANKS' salt solution containing 20 mM
HEPES (pH 7.0), permeabilized in phosphate buffered saline (PBS)
containing 0.1% Triton X-100 and 1% BSA for 5 min followed by
incubationwith anti-pPKCɛ antibody. After treatment with ﬂuorescein
isothiocyanate (FITC) conjugated secondary antibody (1:100), cover-
slips were mounted in glycerol/PBS and viewed under ﬂuorescence
microscope (Olympus BX51 microscope, Tokyo, Japan). The images
were capturedwith cool snap pro camera.When immunoﬂuorescence
study demonstrated transfection of pPKCɛ into the cells, the rest of the
cells transfected with pPKCɛ were incubated with insulin to observe
pPKCɛ effect on insulin activity.
2.9. Autoradiography of radiolabelled PKCɛ and NF-κB
Cell lysates from palmitate incubated cells containing [γ-32P] ATP
were centrifuged for 10 min at 10,000 g and supernatant was
subjected to Microcon ﬁlter devices (Millipore Co., Betford, MA,
USA) through YM-50 and then YM-100, ﬁltrate from YM-100 was
collected and solubilized with PBS buffer (50 mM, pH-7.4). This was
subjected to immunoprecipitation by following a previous description
from our laboratory [35]. Brieﬂy, 200 μg protein from cell lysates was
incubated overnight at 4 °C with 2 μg pPKCɛ antibody. 50 μl of protein
A-Sepharose was added to each tube and incubated at 4 °C for 2 h
followed by centrifugation at 10,000 g. The immuno-complex of
pPKCɛ formed was dissolved in 500 μl of 0.1% CHAPS in PBS. Purity of
32pPKCɛ was examined in 10% SDS-PAGE prior to autoradiography
where it gave a clear single band around 90 kDa indicating the
homogeneity of 32pPKCɛ. 10 μg of 32pPKCɛ was then added to a
reaction mixture containing 10 μM MgCl2, 10 μg puriﬁed NF-κB p65.
The reaction was carried out for 20 min at 25 °C and terminated by
addition of 40 μl of 1× SDS sample buffer [39]. Autoradiography was
performed for both 32pPKCɛ (after its puriﬁcation) and the reaction
mixture where it was incubated with NF-κB. 20 μl of aliquot in each
case was resolved on 10% SDS-PAGE, transferred to PVDF membrane
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2.10. Statistical analysis
Data were analysed by one-way analysis of variance (ANOVA)
where the F value indicated signiﬁcance, means were compared by a
post hoc multiple range test. Densitometric analysis was done by
using Image J software. All values were means±SEM.
3. Results
3.1. Incubation of skeletal muscle cells with palmitate augmented
phosphorylation and expression of NF-κB p50 and NF-κB p65
We previously demonstrated that free fatty acid i.e. palmitate,
effects insulin resistance in skeletal muscle cells by inhibiting insulin
receptor gene expression and that in turn abrogated insulin signaling
pathway [32,33]. NF-κB is known to be related to insulin resistance
and type2 diabetes. We wanted to examine the role of NF-κB in fatty
acid induced impairment of insulin signaling pathway. Fig. 1A shows
that palmitate signiﬁcantly increased the phosphorylation of NF-κB
p65 and NF-κB p50 as compared to control (pb0.01 for p65 andFig. 1. Palmitate stimulation of both NF-κB p65 and NF-κB p50 protein expression and ph
incubated with 0.75 mM palmitate for 4 h and changes in the NF-κB p65 and NF-κB p50 pro
using speciﬁc antibodies raised against NF-κB p65, phospho-NF-κB p65, NF-κB p50 and pho
incubated with 0.75 mM palmitate at different time periods (from 0 to 6 h), cells were lysed
each treatment, skeletal muscle cells treated with insulin (I) or palmitate (P) or none (C) we
procedure described in the text. Densitometric analysis was done by using Image J software. M
with the insulin; #pb0.05 in comparison to insulin.pb0.05 for p50) while insulin had no effect. We used anti-NF-κB
antibody as loading control to substantiate the increase in NF-κB
phosphorylation due to fatty acid. Surprisingly, we observed that
palmitate markedly increased NF-κB p50 and NF-κB p65 protein
expression (pb0.01) as compared to control or insulin incubation of
skeletal muscle cells. In a time kinetics study, it was observed that
incubation of skeletal muscle cells with palmitate augmented both
phosphorylation and protein expression of NF-κB p65 at 4 and 6 h
which corresponded to the decrease of insulin stimulated 3[H] 2-DOG
uptake by palmitate (Fig. 1B). A signiﬁcant increase of NF-κB p65
protein and phosphorylation at the same time by palmitate indicates
an involvement of NF-κB in the impairment of insulin activity. Fig. 2A
shows that palmitate increased NF-κB p50 and NF-κB p65 at a dose of
0.5 and 0.75 mM, whereas 0.25 mM had no effect; there was no
additional increase by 1.0 mM over the 0.75 mM. Transfection of NF-
κB p65 siRNA into the skeletal muscle cells followed by palmitate
incubation did not show increase in NF-κB protein expression
indicating palmitate effect on pNF-κB p65 transcription (Fig. 2B).
3.2. Puriﬁcation of palmitate-induced NF-κB p65 protein
Skeletal muscle cells incubated without (control) or with palmitate
were lysed by sonication, centrifuged at 10,000 g for 10 min andosphorylation is associated with insulin resistance. (A) L6 skeletal muscle cells were
tein expression and level of phosphorylation were detected by Western blot analysis by
spho-NF-κB p50. β actin was used as loading control. (B) L6 skeletal muscle cells were
and subjected to Western blot analysis. To estimate the [3H] 2-deoxyglucose uptake for
re sonicated, centrifuged and counted in a liquid scintillation counter according to the
eans±SEMwas determined from ﬁve independent experiments; ⁎pb0.01 as compared
Fig. 2. Effect of varied doses of palmitate on NF-κB expression. (A) L6 skeletal muscle cells were incubated with different doses of palmitate for 4 h, on termination of incubation cell
lysates were subjected toWestern blot analysis by using speciﬁc antibodies raised against NF-κB p65 and NF-κB p50. β actin was used as loading control. (B) NF-κB p65 siRNA blocks
the palmitate induced expression of NF-κB p65. Skeletal muscle cells were incubated with palmitate (P) or palmitate plus NF-κB p 65 siRNA (P+siRNA) or any of them (C). Western
blot analysis was performed using anti-NF-κB p65 antibody. Densitometric analysis was done by using Image J software. Means±SEM was calculated from ﬁve independent
experiments; ⁎pb0.01; ⁎⁎pb0.001 in comparison to control.
Fig. 3. Puriﬁcation of NF-κB protein. (A) Control and palmitate incubated (4 h) L6 skeletal muscle cell lysates were resolved on a 10% SDS-PAGE. A clear band at the 65 kDa region
indicates overexpression of NF-κB p65 protein. (B) L6 skeletal muscle cells were incubatedwith palmitate and cell lysates after centrifugationwas loaded on a Sephadex G-75 column.
A control was run parallely to compare the effect of palmitate. Separately collected fractions (such as A1, A2 and A3) from control and palmitate treated cell lysates were
immunoblotted with anti-NF-κB p65 antibody. The lanes A1 and A2 shows the immunoreactive bands of NF-κB (inset of B). (C) The pooled fractions from gel ﬁltration
chromatography were lyophilized and loaded on a immunoafﬁnity columnwhere CNBr activated Sepharose 4B was coupled with anti-NF-κB antibody. P1 (unbound protein) and P2
(bound fraction eluted with 2 M KI) peaks were collected, subjected to Western blot analysis, P2 protein immunoreacted with anti-NF-κB antibody (inset of C).
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Fig. 4. Palmitate induced NF-κB gene expression. (A) Total RNAwas isolated from L6 skeletal muscle cells incubated with palmitate for different time periods (0–6 h) and RT-PCR was
performed using speciﬁc primers for NF-κB. A house keeping gene gapdhwas ampliﬁed simultaneously to serve as an internal control. (B) L6 skeletal muscle cells incubated without
(C) or with palmitate (P) or palmitate plus NF-κB p65 siRNAwere subjected to RT-PCR analysis. (C) L6 skeletal muscle cells incubatedwith or without palmitate for 4 h were subjected
to real-time PCR experiment in which NF-κB mRNA expression was quantitatively measured using gapdh as an internal control. Values represent means±SEM of three independent
experiments. ⁎pb0.001 in comparison to control.
195P. Barma et al. / Biochimica et Biophysica Acta 1792 (2009) 190–200supernatant was loaded on 10% SDS-PAGE gel. Fig. 3A demonstrates
that palmitate incubation overexpressed p65 protein. The supernatant
was then loaded on Sephadex G-75 column and the elution proﬁle
showed an increase of 65 kDa protein due to palmitate incubation. TheFig. 5. Relationship between NF-κB overexpression and activation. (A) Nuclear extracts (NE)
plus NF-κB p65 siRNA or SN50 or siRNA control or without any of them (control) followed by
determine the speciﬁcity of NF-κB binding. The lanes are: lane 1—probe, lane 2—control, lan
palmitate+siRNA control and lane 7—palmitate+anti-NF-κB antibody (represents the supers
p65 binding to DNA. (B) Levels of palmitate induced phosphorylation of IKK and IκB were det
plus NF-κB p65 siRNA (P+NF-κB siRNA) or palmitate plus SN50 (P+SN50) or without any of t
IκBα protein served as loading controls. (C) L6 skeletal muscle cells incubated with insulin (I)
(control) for 4 h to determine [3H] 2-deoxyglucose uptake. Values represent means±SEM ofeluted fractions of this area were pooled, lyophilized and subjected to
Western blot analysis with anti-NF-κB p65 antibody. The inset of
Fig. 3B demonstrates that both A1 (control) and A2 (palmitate treated)
fractions crossreacted with anti-NF-κB p65 antibody; there was awere prepared from L6 skeletal muscle cells incubated for 4 h with palmitate, palmitate
EMSA. Both wild type (lanes 2–7) and mutant (lanes 8–11) DNA sequences were used to
e 3—palmitate, lane 4—palmitate+NF-κB p65 siRNA, lane 5—palmitate+SN50, lane 6—
hift assay) and lanes 8 to 11—denotes the mutant probe to verify the speciﬁcity of NF-κB
ermined in skeletal muscle cells incubated in the presence of palmitate (P) or palmitate
hem (C) using anti-pIKK and anti-pIκBα antibodies as probes. Immunoblots for IKK and
, insulin+palmitate (P+ I), insulin+palmitate+SN50 (P+I+SN50) or without any of them
three independent experiments, ⁎pb0.01 (I vs P+I) and ⁎⁎pb0.05 (P+I vs P+I+SN50).
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fraction was then loaded on an immunoafﬁnity column where anti-
NF-κB p65 antibody was linked to Sepharose 4B (Fig. 3C). Fractions
eluted with buffer (P1) or eluted with KI as chaotropic agent (P2) were
lyophilized and examined by Western blot analysis. P2 was found to
be pure NF-κB p65 protein (inset of Fig. 3C). Purity of p65 was veriﬁed
in SDS-PAGE which showed a clear single band protein at 65 kDa zone
(data not shown).
3.3. Palmitate overexpressed p65 NF-κB gene
Palmitate induced increase in NF-κB protein expression and its
inhibition by NF-κB p65 siRNA suggests palmitate effect on NF-κB
gene expression. To examine this, skeletal muscle cells were incubated
in varied time periods with palmitate and RT-PCR showed that NF-κB
p65 gene expression was detectably increased at 2 h; it was further
increased at 4 h and expression level remained same at 6 h (Fig. 4A). In
NF-κB p65 siRNA transfected L6 muscle cells, palmitate incubation did
not increase NF-κB gene expression (Fig. 4B). Real time PCR data
demonstrated a highly signiﬁcant (pb0.001) quantitative increase of
NF-κB p65 mRNA due to palmitate (Fig. 4C).
3.4. Inhibition of palmitate induced NF-κB expression reduced
its activation
The pathway of NF-κB activation is well known. Activation of
inhibitor of κB kinase (IKK) phosphorylates IκB, an inhibitor of NF-κB;
phosphorylated IκB is degraded releasing NF-κB for its translocation to
the nucleus which regulates expression of a number of genes. Fatty
acid induced elevation of NF-κB activity has been reported earlier
[21,26]. To examine whether fatty acid induced overexpression of
NF-κB is related to its activity, we performed EMSA with palmitate
incubated skeletal muscle cells. NF-κB p65 binding activity increased
in nuclear extract from palmitate treated cells. Addition of antibody
against NF-κB p65 supershifted the binding complex suggesting that
this band is mainly constituted by this subunit, this was not observedFig. 6. Relationship between activated PKCɛ and NF-κB p65 protein expression. (A) L6 skele
Western blot analysis was performed with anti-pPKCɛ and anti-NF-κB p65 antibodies. (B) E
induced NF-κB p65 protein expression. Densitometric analysis was carried out using Image J s
vs 4 h); ⁎⁎pb0.001 (P vs Cal C or ɛV1).in the nuclear extract from control cells. To check the speciﬁcity of
NF-κB p65 and DNA interactions, we used a mutant of NF-κB which
did not show any binding activity. Incubation of NF-κB p65 siRNA
transfected L6 skeletal muscle cells with palmitate signiﬁcantly
inhibited palmitate induced augmentation of NF-κB p65 binding to
DNA. Addition of SN50, a translocation inhibitor of NF-κB, to palmitate
incubation which signiﬁcantly reduced palmitate induced increase in
NF-κB binding to DNA (Fig. 5A). Two aspects are indicated from these
observations — i) increase of NF-κB expression due to fatty acid is
linked to a greater binding to DNA implicating its augmented
activation and ii) decrease of NF-κB binding by NF-κB p65 siRNA
and SN50 suggests regulation of NF-κB expression by NF-κB. Palmitate
induced phosphorylation of IKK and IκB was not adversely affected by
NF-κB inhibition indicating reduction of NF-κB synthesis is not linked
to IKK and IκB activation or deactivation under present experimental
conditions (Fig. 5B). Association of NF-κB in insulin resistance was
indicated by the improvement of the inhibition of insulin stimulated
[3H] 2-DOG uptake due to SN50 (Fig. 5C).
3.5. Phosphorylation of PKCɛ by palmitate is associated with NF-κB
p65 overexpression
We have reported earlier that incubation of skeletal muscle cells
with palmitate phosphorylated PKCɛ [31] and a link between FFA
induced NF-κB activation and novel PKCs has also been demonstrated
[40]. These reports prompted us to examine whether overexpression
of NF-κB p65 by palmitate is mediated through PKCɛ. Fig. 6A shows a
time dependent increase in PKCɛ phosphorylation due to palmitate
which increased from 2 to 4 h, incubation at 6 h did not show
signiﬁcant difference from 4 h. This coincidedwith the overexpression
of NF-κB p65. Addition of PKC inhibitor, Calphostin C, decreased
palmitate induced overexpression of NF-κB p65. Incubation of PKCɛ
translocation inhibitor, ɛV1, with palmitate signiﬁcantly (pb0.001)
reducing palmitate stimulation of NF-κB p65 expression (Fig. 6B)
indicative of involvement of PKCɛ in the palmitate induced over-
expression of NF-κB p65.tal muscle cells were incubated with palmitate for different time periods (0–6 h) and
ffect of PKC inhibitor, Calphostin C and PKCɛ translocation inhibitor ɛV1 on palmitate
oftware. Means±SEMwas calculated from ﬁve independent experiments. ⁎pb0.001 (0 h
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was prevalent as compared to its phospho form; while in palmitate
incubated cells situationwas reverse, therewasmore phospho form of
PKCɛ than its non phospho form. Increased pPKCɛ coincided with the
increased phospho NF-κB and higher expression of NF-κB (Fig. 7A).
Use of PKC inhibitor, Calphostin C and NF-κB translocation inhibitor,
SN50 reduced pPKCɛ and pNF-κB along with the reduction of NF-κB
expression in palmitate incubated skeletal muscle cells. Inhibition of
NF-κB transcription by NF-κB p65 siRNA did not alter the status of
PKCɛ or pPKCɛ indicating PKCɛ in the upstream of NF-κB (Fig. 7B).
These results implicate palmitate induced pPKCɛ's involvement in the
activation of NF-κB which may lead to overexpression of NF-κB. To
examine this, we incubated L6 skeletal muscle cells without (control)
or with palmitate in the presence of γ32pATP. Since palmitate induces
a constitutive phosphorylation of PKCɛ [32,33], radiolabelled phos-
phate is expected to be incorporated into the PKCɛ. Palmitate
incubated cells were lysed, centrifuged and supernatant was subjected
to immunoprecipitation using anti-pPKCɛ antibody. Puriﬁed radiola-
belled PKCɛ was loaded on SDS-PAGE followed by autoradiography
which showed that a considerable amount of 32pPKCɛ could be
obtained from palmitate incubated cells (Fig. 7C). 32pPKCɛ was then
incubatedwith NF-κB p65 in cell free systemwith the expectation that
if activated PKC has kinase activity with NF-κB, transfer of radi-
olabelled phosphate from PKCɛ to the NF-κB will occur. On termina-
tion of incubation, reaction mixture was subjected to SDS-PAGE
followed by autoradiography. From a parallel incubation, after autora-
diography radioactive zone on PVDF membrane was cut to determine
the radioactive count in a liquid scintillation counter. Fig. 7D
demonstrates that radioactive phosphate from 32pPKCɛ was trans-
ferred to NF-κB. These results suggest that pPKCɛ phosphorylates NF-Fig. 7. Palmitate induced phosphorylation of NF-κB is mediated by pPKCɛ. (A) L6 myotubes w
cells were lysed and immunoblotted with anti-PKCɛ, anti-pPKCɛ, anti-pNF-κB p65 and anti-N
and with different inhibitors as mentioned in the lower panel. SN50 and calphostin C were a
described in the Materials and methods section. After termination of treatment the cells wer
NF-κB p65 antibodies. (C) L6 myotubes were incubated for 4 h without (C) or with palmitat
followed by 10% SDS-PAGE and 32P-labelled pPKCɛwas visualized by autoradiography (upper
scintillation counter. (D) For in vitro kinase assay, radiolabelled pPKCɛ was incubated in vitro
terminated by boiling the reaction mixture in SDS sample buffer and resolved in 10% SDS-PA
was determined by liquid scintillation counter.κB p65 which is translocated to the nuclear region and expresses the
NF-κB p65 gene.
3.6. Transduction of pPKCɛ to L6 skeletal muscle cells inhibited
insulin activity
To examine the possibility that pPKCɛ may activate NF-κB p65
which in turn augmented its gene expression, we transducted puriﬁed
pPKCɛ into the cells (Fig. 8A). As expected, Western blot analysis
showed a signiﬁcantly greater concentration of pPKCɛ in the
transducted cells in comparison to the control cells. Increase in
pPKCɛ coincided with increased pNF-κB p65 and overexpression of
NF-κB p65 (Fig. 8B). These results indicate that increase of pPKCɛ form
due to palmitate mediates NF-κB p65 expression via the activation of
NF-κB p65. If this is true, then pPKCɛ transducted cells would
demonstrate insulin resistance. It can be seen from Fig. 8C and D
that insulin stimulated translocation of GFP-Glut4 into the cell
membrane and uptake of 3[H] 2-DOG, which are dependable markers
to assess insulin activity, were signiﬁcantly abrogated in pPKCɛ
transducted cells. Presumably, cells loaded with pPKCɛ would have
increased expression of NF-κB and that in turn attenuated insulin
activity.
3.7. Acute and chronic effects of palmitate on NF-κB expression
To compare the acute and chronic effects of palmitate on NF-κB
expression, we have used two different doses i.e. 0.75 mM and
0.25mM. Throughout our experimentswe observed the acute effect of
palmitate using the concentration of 0.75 mM by following previous
descriptions [32,33,41–43]. To observe the chronic effect, L6 skeletalere incubated for 4 h without (control) or with palmitate. On termination of incubation,
F-κB p65 antibodies. (B) L6 myotubes were incubated for 4 h without or with palmitate
dded to respective incubations 1 h before addition of palmitate. siRNA transfection was
e harvested for Western blot analysis with anti-PKCɛ, anti-pPKCɛ, pNF-κB p65 and anti-
e (P) in the presence of [γ-32P] ATP. Cells were lysed, immunoprecipitated with pPKCɛ
panel). % incorporation of radiolabelled phosphate into PKCɛwas determined by liquid
with or without (control) pure NF-κB p65 protein for 20 min at 25 °C. The reaction was
GE followed by autoradiography. % incorporation of radiolabelled phosphate into NF-κB
Fig. 8. Delivery of pPKCɛ protein into the cells causes impairment of insulin activity. (A) pPKCɛ protein was delivered in L6 skeletal muscle cells and its incorporationwas detected by
immunoﬂuorescence. (B) Control and pPKCɛ transducted cells (PTC) were subjected to Western blot analysis with anti-pPKCɛ, anti-pNF-κB p65 and anti-NF-κB p65 antibodies. (C)
GFP-Glut 4 construct was transfected into the skeletal muscle cells and incubated with insulin (I) or I+pPKCɛ protein or with none (C—control). On termination of incubation, GFP-
Glut 4 localization was detected by using laser scanning confocal microscope. (D) The same set of incubations was used to determine the [3H] 2-deoxyglucose uptake. Values
represent means±SEM of three independent experiments, ⁎pb0.01 (I vs I+PTC).
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With 0.75 mM palmitate, both NF-κB p65 gene and protein
expressions were at peak at 4 h (as depicted in Figs. 4 and 6) as no
additional NF-κB expression occurred in spite of longer duration of
incubation. In contrast, 0.25 mM palmitate showed a chronic effect
demonstrating no effect until 8 h. At 16 h p65 gene and protein ex-
pressions began to appear, reaching the peak at 24 h since 48 h had no
additional effect (Fig. 9A and B). Similar results were obtained withFig. 9. Effect of chronic treatment of L6 myotubes with palmitate on NF-κB expression.
(A) L6 myotubes were incubated with palmitate (0.25 mM and 0.75 mM doses) for 16 h,
24 h and 48 h, total RNAwas isolated and subjected to RT-PCR analysis. A house keeping
gene gapdh was ampliﬁed simultaneously to serve as an internal control. (B) L6
myotubes were incubated with palmitate (0.25 mM and 0.75 mM doses) for 0–48 h as
mentioned in the upper panel and subjected to Western blot analysis with anti-NF-κB
p65 antibody. β actin was used as loading control.pPKCɛ and pNF-κB p65 (data not shown) again suggesting 0.75 mM to
be an acute dose while 0.25 mM of palmitate produced chronic effect.
4. Discussion
There are two important information generated from the present
investigation — (1) overexpression of NF-κB due to palmitate is
associated with insulin resistance and (2) this effect of palmitate is
mediated through the activation of PKCɛ. It is fairly well known that
lipid-induced insulin resistance and type2 diabetes is linked to the
activation of NF-κB [1,2,5,22]. Our observation of NF-κB overex-
pression due to FFA appeared serendipitously whenwewanted to ﬁnd
a link between FFA induced downregulation of insulin receptor (IR)
gene expression, as reported previously from this laboratory [32], and
FFA induced activation of NF-κB. In searching the underlying
mechanism about how FFA i.e. palmitate inhibits IR gene and protein
expression in skeletal muscle cells, we have found that palmitate
phosphorylated PKCɛ in cytosol which is then translocated to the
nuclear region and is associated with the inhibition of IR gene
expression [33]. Relationship between novel PKC and NF-κB has been
indicated by several authors [29,30,39,44]. We therefore thought it
relevant to investigate whether NF-κB is associated in this pathway of
FFA induced impairment of insulin activity. With this assumption we
incubated L6 skeletal muscle cells with palmitate and found a
signiﬁcant increase in NF-κB activation as reported by others [21,28],
but at the same time we were surprised to observe a remarkable
increase of NF-κB protein in the immunoblot probed with anti-NF-κB
p65 and anti-NF-κB p50 antibodies.
Another interesting ﬁnding is the relationship between NF-κB p65
protein expression and its phosphorylation. Palmitate at a dose of
0.75 mM induced NF-κB p65 gene and protein expression could be
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less than 4 h incubation. This is the time when phosphorylated NF-κB
p65 crosses the nuclear membrane and binds to DNA of skeletal
muscle cells in response to palmitate. These data suggest that FFA
induced activation of NF-κB may be associated with its overexpres-
sion. However, such time-kinetics events are not similar in chronic
incubation with 0.25 mM palmitate. Proximal element of pro-
inﬂammatory response is initiated by IKK which phosphorylates IκB
that inhibits nuclear translocation of NF-κB. Phosphorylation of IκB
results its ubiquitination and degradation thus permitting the release
of NF-κB for nuclear translocation to activate gene expression [45]. A
short term lipid infusion in human being induces insulin resistance in
skeletal muscle and also reduces IκB levels indicating a relationship
between the activation of NF-κB and insulin resistance [14]. This has
been further supported by a reportwith L6 skeletal muscle cells where
palmitate augments nuclear translocation of NF-κB causing insulin
resistance. Inhibition of NF-κB nuclear translocation due to palmitate
also blocks palmitate induced insulin resistance [21]. Thus activation
of NF-κB by palmitate is associated with the impairment of insulin
activity. We have observed another facet of the palmitate–NF-κB
relationship. Palmitate induced overexpression of NF-κB in skeletal
muscle cells is also related to insulin resistance. Incubation of NF-κB
p65 siRNA transfected cells with palmitate reduced its inhibitory
effect on insulin stimulated [3H] 2-DOG uptake. Since this inhibition is
very speciﬁc, it implicates that overexpression of NF-κB due to
palmitate could be associated with its activation. This is further
strengthened by the ﬁndings that demonstrate a reduction of NF-κB
binding to DNA due to NF-κB p65 siRNA and SN50, as these inhibitors
have not affected palmitate induced IKK and IκB phosphorylation.
These results indicate that increase in internal cellular pool of NF-κB
having an inﬂuence on its enhanced binding to DNA, may be via the
increased turnover of IKK/IκB/NF-κB pathway. This event is also
reﬂected by the impairment of insulin stimulated Glut4 translocation
and glucose uptake due to pPKCɛ transduction which increased both
activation and expression of NF-κB.
While searching for the possible mechanism of palmitate induced
NF-κB gene and protein expressions, we investigated the involvement
of a novel PKC i.e. PKCɛ for the following reasons. A report from this
laboratory showed that palmitate induced phosphorylation of PKCɛ in
the cytosol of skeletal muscle cells was independent of PDK1. pPKCɛ is
then translocated to the nuclear region and on associating with the
inhibition of insulin receptor gene expression compromises with the
insulin sensitivity resulting insulin resistance [32,33]. A recent report
demonstrated that PKCɛ plays an important role in mediating lipid
induced hepatic insulin resistance, as knocking down of PKCɛ
expression reverses fat induced impairment of hepatic insulin
signaling [46]. PKCɛ has been implicated in regulating NF-κB
activation in thymocytes [44] and cardiomyocytes [29]. When we
incubated skeletal muscle cells with palmitate, a detectable increase
of PKCɛ phosphorylation was found to occur at 2 h which further
increased at 4 h remaining at the level till 6 h. Pattern of PKCɛ
activation due to palmitate coincided with the expression of NF-κB
which was signiﬁcantly augmented at 4 h. However, this is not an
evidence of a direct link of activated PKCɛ with NF-κB expression. We
therefore used Calphostin C, a general PKC inhibitor, which effectively
decreased NF-κB expression. The convincing evidence came from
PKCɛ translocation inhibitor ɛV1 experiment. ɛV1 inhibits the trans-
location of PKCɛ and its addition to skeletal muscle cell incubation
with palmitate reversed palmitate stimulation of NF-κB expression.
Since ɛV1 is a speciﬁc inhibitor of PKCɛ translocation, involvement of
PKCɛ in mediating FFA induced NF-κB expression seems to be a
reasonable possibility.
Although these evidences implicate PKCɛ involvement in NF-κB
expression but they do not answer how PKCɛ could regulate such an
expression. To answer this question, we performed a few experiments
to demonstrate a molecular link between activated PKCɛ and NF-κBactivation. Phosphorylation and dephosphorylation of NF-κB is a
major regulatory event for NF-κB nuclear translocation following its
dissociation from IκBα. Although a number of kinases, such as PKA
[47–49], casein kinase II [50–52] and PKCs [14,53] are shown to cause
NF-κB phosphorylation, a clear understanding about different phos-
phorylatory sites and their role in NF-κB function remains an
important requirement. That the activation of PKCɛ at the upstream
is a need to activate NF-κB has been suggested by several authors
[54–56]. It has also been shown that PKCɛ is an important signal
transducer for RhoA mediated activation of NF-κB in human mono-
cytes [57]. We have demonstrated that palmitate causes a prevalence
of phospho-PKCɛ form in skeletal muscle cells; isolation and
puriﬁcation of this form followed by incubation with NF-κB p65 in a
cell-free system show a transfer of phosphate from PKCɛ to NF-κB.
Hence, pPKCɛ activates NF-κB which in turn expresses NF-κB gene on
its translocation to the nucleus. Use of inhibitors also exhibited pPKCɛ
to be an upstream regulator of NF-κB activation. Interestingly, our
ﬁndings indicate the existence of an autoregulatory pathway of NF-κB.
This concept of autoregulatory loop has already been put forwarded
by some authors by demonstrating that NF-κB and IκBα are creating
such a loop [58] and serine phosphorylation of IκB by TNF-α
downregulates NF-κB DNA binding and decreased expression of
p65/p50 [59]. We show here that palmitate induced overexpression of
NF-κB p65 gene could be blocked by NF-κB translocation inhibitor. In
summary, our present observation focused certain interesting aspects
of lipid induced NF-κB in skeletal muscle cells. Palmitate augmented
NF-κB gene and protein expression in skeletal muscle cells by indu-
cing the phosphorylation of PKCɛ which in turn activates NF-κB. This
increase of NF-κB in the cellular pool adversely affected insulin
sensitivity. Since NF-κB is a proinﬂammatory master switch inducing
insulin resistance, the present information would be important to
devise a therapeutic approach for type2 diabetes.
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